BioVersys AG

BioVersys AG financial statements

BioVersys AG's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueCHF 800KEODHD
Net income−CHF 21.83MEODHD
Cash and equivalentsCHF 82.5MEODHD

BioVersys AG financials on 6ix · BioVersys AG on 6ix